0001209191-23-045215.txt : 20230809 0001209191-23-045215.hdr.sgml : 20230809 20230809172800 ACCESSION NUMBER: 0001209191-23-045215 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230807 FILED AS OF DATE: 20230809 DATE AS OF CHANGE: 20230809 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wettig Thane CENTRAL INDEX KEY: 0001815638 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36740 FILM NUMBER: 231156381 MAIL ADDRESS: STREET 1: C/O FIBROGEN, INC. STREET 2: 409 ILLINOIS STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94158 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: FIBROGEN INC CENTRAL INDEX KEY: 0000921299 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 409 ILLINOIS STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 415-978-1200 MAIL ADDRESS: STREET 1: 409 ILLINOIS STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94158 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-08-07 0 0000921299 FIBROGEN INC FGEN 0001815638 Wettig Thane C/O FIBROGEN, INC. 409 ILLINOIS STREET SAN FRANCISCO CA 94158 0 1 0 0 Chief Commercial Officer 0 Common Stock 2023-08-07 4 A 0 200000 0.00 A 308261 D Stock Option (Right to Buy) 1.77 2023-08-07 4 A 0 300000 0.00 A 2033-08-06 Common Stock 300000 300000 D Represents the grant of Restricted Stock Units ("RSUs") that vest quarterly over 1 year from August 1, 2023, subject to the reporting person's continued service with the company on each such date. Twenty-Five percent of the shares subject to the option vest on August 7, 2024 and the remainder vest quarterly in equal installments over the following 3 years, subject to the reporting person's continued service with the company on each such date. /s/ Cecelia Monoarfa-Taime, Attorney-in-fact 2023-08-09